STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read full article →Medicare Monitor
Tracking Medicare news, policy, and coverage changes.
Texas AG investigating energy drinks
The limitations of private health insurance, the quiet collapse of America's research ethics watchdog and other Morning Rounds news
Read full article →STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review program
Read full article →The World Cup vs. bugs, germs and heat: Here's the game plan
Despite a diminished federal presence, public health departments are preparing for common ailments that could afflict fans who gather for the event — and are keeping an eye on the Ebola outbreak, too.
Read full article →Deadly Cheese-Linked Outbreak; 15 Med Schools Probed; 'Concern' on FDA Voucher Pilot
(MedPage Today) -- Note that some links may require registration or subscription. FDA said a multi-year Listeria monocytogenes outbreak linked to soft ricotta/requeson cheese sold in Maryland, New York, and Virginia has hospitalized seven people...
Read full article →Ascension closes AmSurg deal following FTC scrutiny
Regulators cleared the nonprofit’s $3.9 billion AmSurg acquisition — but with conditions.
Read full article →WellSpan Health strikes strategic partnership with Philips to deploy, co-develop new healthcare tech
WellSpan Health inked a seven-year strategic alliance with Philips to drive advanced imaging technology across its network and co-develop new healthcare technology.
Read full article →Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
The platform—dubbed Informed Pain Care—allows patients to connect with licensed clinicians virtually, providing symptom-based intake and eligibility screenings and treatment options.
Read full article →FDA reviewing safety of abortion drug mifepristone
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data...
Read full article →Millions of Kids Could Lose Insurance as GOP Healthcare Cuts Start To Bite
Big cuts to healthcare programs in the 2025 GOP budget law are creating an affordability crunch for many Americans: Higher health insurance premiums. Confusion about whom Medicaid will cover under the new rules. KFF Health News chief Washington correspondent Julie Rovner explains how the changes could leave nearly 2 million children uninsured.
Read full article →Upcoming Billing Change Could Make Pregnancy Pricier
Come January, pregnancy care physician billing codes will change from a bundled system to an à la carte one. Many obstetricians say this approach will better reflect the amount and type of care they provide. But it could incentivize providers to pile on visits and services.
Read full article →‘We Live With Fear’: In Congo, Doctors Face Ebola With Little Protection
Travel bans and conflict have disrupted supply chains in the Democratic Republic of Congo, leaving health workers without Ebola tests and protective gear needed to contain the outbreak.
Read full article →